Home › Funds › CADEN CAPITAL PARTNERS, LP › AMGN

CADEN CAPITAL PARTNERS, LP position in AMGN

AMGEN INC · Health Care

CADEN CAPITAL PARTNERS, LP reported holding 712 shares of AMGN (AMGEN INC) in its Q2 2026 13F filing — a position valued at US$258K, representing 3.11% of its reported portfolio and ranking #7 among its reported holdings. CADEN CAPITAL PARTNERS, LP has disclosed AMGN holdings in 3 of the last 3 reported quarters, going back to Q4 2025.

Latest position (Q2 2026)712 sh
Reported value held$257.83K
Portfolio Weight3.11%
First reportedQ4 2025
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How CADEN CAPITAL PARTNERS, LP's AMGN position evolved

CADEN CAPITAL PARTNERS, LP first disclosed a stake in AMGN in Q4 2025 at 296 shares (US$97K). The position peaked in Q2 2026 at 712 shares, worth US$258K. Across 3 filings, CADEN CAPITAL PARTNERS, LP increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 1 time(s). The most recent filing (Q2 2026) shows 712 shares valued at US$258K. Notable position changes include a 141% increase in Q1 2026 (shares rose 3% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2025 296 $96.88K New
Q1 2026 712 $250.52K Add
Q2 2026 712 $257.83K Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About AMGN and 13F data

AMGN (AMGEN INC) is a Health Care company. 32 other funds we track also report a position in AMGN — the largest reported positions include BlackRock Inc (US$17.87B), STATE STREET CORP (US$10.75B), Capital World Investors (US$10.53B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding AMGN

All AMGN fund holders →

FAQ

How long has CADEN CAPITAL PARTNERS, LP held AMGN?

CADEN CAPITAL PARTNERS, LP has disclosed AMGN holdings in 3 of the last 3 reported quarters, going back to Q4 2025.

What is CADEN CAPITAL PARTNERS, LP's current position in AMGN?

As of Q2 2026, CADEN CAPITAL PARTNERS, LP holds 712 shares of AMGN (AMGEN INC), valued at $257.83K, representing 3.11% of its reported portfolio and ranking #7.

Has CADEN CAPITAL PARTNERS, LP been buying or selling AMGN?

In the latest 13F filing (Q2 2026), CADEN CAPITAL PARTNERS, LP held unchanged its position in AMGN. The position peaked in Q2 2026 at 712 shares.

Which other funds hold AMGN?

Other major institutional holders of AMGN include BlackRock Inc, STATE STREET CORP, Capital World Investors, among 32 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.